Multicenter prospective observation study of salvage-line bevacizumab for unresectablemetastatic colorectal cancer in Okayama

ABSTRACT: Primary outcome(s): PFS; progression-free survival

DISEASE(S): Colorectal Cancer

PROVIDER: 2626332 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR